Condition

Type 2 Diabetes Mellitus, CKD and Albuminuria

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions3

Lead sponsors shown1

Clinical trials

1 shown

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDNCT02547935 · 2015-09-21

COMPLETED

Common interventions

Dapagliflozin 10 mgDRUG1Matching Placebo for Dapagliflozin 10 mg and Saxagliptin 2.5mgDRUG1Saxagliptin 2.5 mgDRUG1

Leading sponsors

AstraZeneca1

Trial status mix

COMPLETED1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.